The relationship between brachial ankle pulse wave velocity and complement 1 inhibitor

Journal of Korean Medical Science

Volumn 24, Issue 5, 2009, Pages 831-836

  Chae, Yong Min ^a   Park, Jong Kwon ^a  

^a Sungkyunkwan University School of Medicine   (South Korea)

Author keywords

Complement 1 inhibitor; Pulse wave velocity; Stiffness

Indexed keywords

COMPLEMENT COMPONENT C1S INHIBITOR;

ADOLESCENT; ADULT; AGE; AGED; ANKLE; ANKLE BRACHIAL INDEX; ARTICLE; BLOOD FLOW VELOCITY; BLOOD PRESSURE; BODY MASS; BRACHIAL ARTERY; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; ELASTICITY; FEMALE; HUMAN; MALE; METABOLISM; MIDDLE AGED; PHYSIOLOGY; PREDICTION AND FORECASTING; RANDOMIZED CONTROLLED TRIAL; REGRESSION ANALYSIS; RISK FACTOR; SEX DIFFERENCE; VASCULARIZATION;

ADOLESCENT; ADULT; AGE FACTORS; AGED; ANKLE; ANKLE BRACHIAL INDEX; BLOOD FLOW VELOCITY; BLOOD PRESSURE; BODY MASS INDEX; BRACHIAL ARTERY; COMPLEMENT C1 INHIBITOR PROTEIN; ELASTICITY; FEMALE; HUMANS; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; REGRESSION ANALYSIS; RISK FACTORS; SEX FACTORS;

EID: 75349096966     PISSN: 10118934     EISSN: 15986357     Source Type: Journal    
DOI: 10.3346/jkms.2009.24.5.831     Document Type: Article

References (30)

1. Zanker KS. General introduction to innate immunity: Dr. Jekyl/Mr. Hyde quality of the innate immune system. Contrib Microbiol 2008; 15: 12-20.
2. Caliezi C, Wuillemin WA, Zeerleder S, Redondo M, Eisele B, Hack CE. C1-Esterase inhibitor: an anti-inflammatory agent and its potential use in the treatment of diseases other than hereditary angioedema. Pharmacol Rev 2000; 52: 91-112.
3. Kalter ES, Daha MR, ten Cate JW, Verhoef J, Bouma BN. Activation and inhibition of Hageman factor-dependent pathways and the complement system in uncomplicated bacteremia or bacterial shock. J Infect Dis 1985; 151: 1019-27.
4. Woo P, Lachmann PJ, Harrison RA, Amos N, Cooper C, Rosen FS. Simultaneous turnover of normal and dysfunctional C1 inhibitor as a probe of in vivo activation of C1 and contact activatable proteases. Clin Exp Immunol 1985; 61: 1-8.
5. Kostner KM, Fahti RB, Case C, Hobson P, Tate J, Marwick TH. Inflammation, complement activation and endothelial function in stable and unstable coronary artery disease. Clin Chim Acta 2006; 365: 129-34.
6. Jani B, Rajkumar C. Ageing and vascular ageing. Postgrad Med J 2006; 82: 357-62.
7. Wykretowicz A, Gerstenberger P, Guzik P, Milewska A, Krauze T, Adamska K, Rutkowska A, Wysocki H. Arterial stiffness in relation to subclinical atherosclerosis. Eur J Clin Invest 2009; 39: 11-6.
8. Ridker PM, Silvertown JD. Inflammation, C-reactive protein, and atherothrombosis. J Periodontol 2008; 79 (8 Suppl): 1544-51.
9. van Popele NM, Grobbee DE, Bots ML, Asmar R, Topouchian J, Reneman RS, Hoeks AP, van der Kuip DA, Hofman A, Witteman JC. Association between arterial stiffness and atherosclerosis: the Rotterdam Study. Stroke 2001; 32: 454-60.
10. Yamashina A, Tomiyama H, Takeda K, Tsuda H, Arai T, Hirose K, Koji Y, Hori S, Yamamoto Y. Validity, reproducibility, and clinical significance of noninvasive brachial-ankle pulse wave velocity measurement. Hypertens Res 2002; 25: 359-64.
11. Nicoletti A, Caligiuri G, Hansson GK. Immunomodulation of athero-sclerosis: myth and reality. J Intern Med 2000; 247: 397-405.
12. Kullo IJ, Gau GT, Tajik AJ. Novel risk factors for atherosclerosis. Mayo Clin Proc 2000; 75: 369-80.
13. Rosner B. Fundamentals of Biostatistics. 4th ed. Belmont, California, USA: Duxbury Press 1995.
14. Kim DH, Kim J, Kim JM, Lee AY. Increased brachial-ankle pulse wave velocity is independently associated with risk of cerebral ischemic small vessel disease in elderly hypertensive patients. Clin Neurol Neurosurg 2008; 110: 599-604.
15. Xu Y, Wu Y, Li J, Ma W, Guo X, Luo Y, Hu D. The predictive value of brachial-ankle pulse wave velocity in coronary atherosclerosis and peripheral artery diseases in urban Chinese patients. Hypertens Res 2008; 31: 1079-85.
16. Lappin D, Whaley K. Regulation of C1-inhibitor synthesis by interferons and other agents. Behring Inst Mitt 1989: 180-92.
17. Zuraw BL, Lotz M. Regulation of the hepatic synthesis of C1 inhibitor by the hepatocyte stimulating factors interleukin 6 and interferon gamma. J Biol Chem 1990; 265: 12664-70.
18. Prada AE, Zahedi K, Davis AE 3rd. Regulation of C1 inhibitor synthesis. Immunobiology 1998; 199: 377-88.
19. Windfuhr JP, Alsenz J, Loos M. The critical concentration of C1-esterase inhibitor (C1-INH) in human serum preventing auto-activation of the first component of complement (C1). Mol Immunol 2005; 42: 657-63.
20. Johnson AM, Alper CA, Rosen FS, Craig JM. C1 inhibitor: evidence for decreased hepatic synthesis in hereditary angioneurotic edema. Science 1971; 173: 553-4.
21. Donaldson VH, Rosen FS. Action of complement in hereditary angioneurotic edema: the role of C'1-esterase. J Clin Invest 1964; 43: 2204-13.
22. Natali A, L'Abbate A, Ferrannini E. Erythrocyte sedimentation rate, coronary atherosclerosis, and cardiac mortality. Eur Heart J 2003; 24: 639-48.
23. Buono C, Come CE, Witztum JL, Maguire GF, Connelly PW, Carroll M, Lichtman AH. Influence of C3 deficiency on atherosclerosis. Circulation 2002; 105: 3025-31.
24. Mallika V, Goswami B, Rajappa M. Atherosclerosis pathophysiology and the role of novel risk factors: a clinicobiochemical perspective. Angiology 2007; 58: 513-22.
25. Bisoendial RJ, Kastelein JJ, Stroes ES. C-reactive protein and atherogenesis: from fatty streak to clinical event. Atherosclerosis 2007; 195: e10-8.
26. McLaren JE, Ramji DP. Interferon gamma: a master regulator of atherosclerosis. Cytokine Growth Factor Rev 2009; 20: 125-35.
27. Zahedi K, Prada AE, Davis AE 3rd. Transcriptional regulation of the C1 inhibitor gene by gamma-interferon. J Biol Chem 1994; 269: 9669-74.
28. Tomiyama H, Koji Y, Yambe M, Shiina K, Motobe K, Yamada J, Shido N, Tanaka N, Chikamori T, Yamashina A. Brachial--ankle pulse wave velocity is a simple and independent predictor of prognosis in patients with acute coronary syndrome. Circ J 2005; 69: 815-22.
29. Hung CS, Lin JW, Hsu CN, Chen HM, Tsai RY, Chien YF, Hwang JJ. Using brachial-ankle pulse wave velocity to associate arterial stiffness with cardiovascular risks. Nutr Metab Cardiovasc Dis 2009; 19: 241-6.
30. Farrar DJ, Green HD, Bond MG, Wagner WD, Gobbee RA. Aortic pulse wave velocity, elasticity, and composition in a nonhuman primate model of atherosclerosis. Circ Res 1978; 43: 52-62.